Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Vimedimex Medi – Pharma JSC's Days Sales Outstanding or its related term are showing as below:
STC:VMD's Days Sales Outstanding is not ranked *
in the Biotechnology industry.
Industry Median: 69.01 * Ranked among companies with meaningful Days Sales Outstanding only.
Vimedimex Medi – Pharma JSC's Days Sales Outstanding
increased
from Mar. 2023 (98.46) to Mar. 2025 (130.77).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vimedimex Medi – Pharma JSC Days Sales Outstanding Chart
STC:VMD vs GOVX, MBVXQ, HSTC: Days Sales Outstanding Comparison
For the Biotechnology subindustry, Vimedimex Medi – Pharma JSC's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vimedimex Medi – Pharma JSC Days Sales Outstanding vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Vimedimex Medi – Pharma JSC's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Vimedimex Medi – Pharma JSC's Days Sales Outstanding falls into.
Vimedimex Medi – Pharma JSC Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Days Sales Outstanding of 130.77 mean?
Vimedimex Medi – Pharma JSC (STC:VMD) has a Days Sales Outstanding of 130.77 as of Mar. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Vimedimex Medi – Pharma JSC and its competitors.
Is Vimedimex Medi – Pharma JSC's Days Sales Outstanding too high?
Vimedimex Medi – Pharma JSC's current Days Sales Outstanding is 130.77. The Biotechnology industry median Days Sales Outstanding is 69.01. Vimedimex Medi – Pharma JSC's value of 130.77 is 89.5% above this industry median.
How does Vimedimex Medi – Pharma JSC's Days Sales Outstanding compare to GOVX and MBVXQ?
Vimedimex Medi – Pharma JSC's Days Sales Outstanding of 130.77 can be compared against companies in the Biotechnology industry. The industry median Days Sales Outstanding is 69.01. Vimedimex Medi – Pharma JSC's value of 130.77 is 89.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Biotechnology company?
The median Days Sales Outstanding among Biotechnology companies is 69.01, based on 840 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vimedimex Medi – Pharma JSC's current Days Sales Outstanding of 130.77 is 89.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Vimedimex Medi – Pharma JSC and its competitors. For the Biotechnology industry, the median Days Sales Outstanding is 69.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vimedimex Medi – Pharma JSC's current Days Sales Outstanding is 130.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimedimex Medi – Pharma JSC stock overvalued right now?
Vimedimex Medi – Pharma JSC (STC:VMD) has a current Days Sales Outstanding of 130.77. The current Days Sales Outstanding is 130.77 and 89.5% above the Biotechnology industry median of 69.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Vimedimex Medi – Pharma JSC (STC:VMD), the current Days Sales Outstanding is 130.77 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vimedimex Medi - Pharma JSC is engaged in the production, trading, import, and export of medicines, raw materials for making medicines, biological products, cosmetics, functional foodstuffs, medical equipment, and testing chemicals. It is also involved in renting office buildings; operates bonded warehouses and pharmacy-GSP.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:VMD has been successfully added to your 
